Page last updated: 2024-10-17

cytosine and Prostatic Neoplasms, Castration-Resistant

cytosine has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.

Research Excerpts

ExcerptRelevanceReference
"Current diagnostic tools for prostate cancer lack specificity and sensitivity for detecting very early lesions."1.46Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns. ( Absher, DM; Brooks, JD; Burwell, TC; Cooper, SJ; Davis, NS; Gulzar, ZG; Gunther, DS; Kirby, MK; Lasseigne, BN; Myers, RM; Ramaker, RC; Roberts, BS, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kirby, MK1
Ramaker, RC1
Roberts, BS1
Lasseigne, BN1
Gunther, DS1
Burwell, TC1
Davis, NS1
Gulzar, ZG1
Absher, DM1
Cooper, SJ1
Brooks, JD1
Myers, RM1

Other Studies

1 other study available for cytosine and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.
    BMC cancer, 2017, 04-17, Volume: 17, Issue:1

    Topics: Adult; Aged; Biomarkers, Tumor; Cytosine; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Huma

2017